Similarly, Li et al. (2020) showed that the full-length FKBP51 (isoform 1) inhibits glioma cell proliferation, reduces glioma cell viability, and enhances sensitivity to the chemotherapeutic agent carmustine (BCNU). The gene discussed is FKBP4; the disease is central nervous system cancer.